Financhill
Sell
39

ALBT Quote, Financials, Valuation and Earnings

Last price:
$3.42
Seasonality move :
-12.36%
Day range:
$3.36 - $4.10
52-week range:
$2.11 - $21.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.05x
P/B ratio:
--
Volume:
42.4K
Avg. volume:
1.8M
1-year change:
-53.56%
Market cap:
$3.7M
Revenue:
$1.3M
EPS (TTM):
-$19.98

Earnings Data

Next earnings date for ALBT
May 30
2025
Most recent earnings per share
-$1.82
Missed by $1.82
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALBT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/12/2024 Q3 -- $345.2K -$1.82 -- --
08/19/2024 Q2 -- $327.9K -$2.85 -- --
05/31/2024 Q1 -- $314.6K -$1.80 -- --
12/31/2023 Q4 -- $321.3K -$13.51 -- --
11/14/2023 Q3 -- $331.3K -$2.06 -- --
06/30/2023 Q2 -- $306.9K -$4.05 -- --
03/31/2023 Q1 -- $296.2K -$4.35 -- --
12/31/2022 Q4 -- $296.3K -$3.60 -- --
11/14/2022 Q3 -- $317.4K -$8.40 -- --
08/05/2022 Q2 -- $290.8K -$3.45 -- --
03/31/2022 Q1 -- $297.6K -$3.45 -- --
12/31/2021 Q4 -- $334.2K -$4.05 -- --
09/30/2021 Q3 -- $486.8K -$3.00 -- --
06/30/2021 Q2 -- $280.2K -$4.50 -- --
03/31/2021 Q1 -- $289.8K -$4.50 -- --
12/31/2020 Q4 -- $454.6K -$6.00 -- --
09/30/2020 Q3 -- $325K -$6.00 -- --
06/30/2020 Q2 -- $301.3K -$6.00 -- --
03/31/2020 Q1 -- $297K -$6.00 -- --
12/31/2019 Q4 -- $479.2K -$10.50 -- --
09/30/2019 Q3 -- $383.2K -$7.50 -- --
06/30/2019 Q2 -- $399.7K -$9.00 -- --
03/31/2019 Q1 -- $284.2K -$9.00 -- --
12/31/2018 Q4 -- $344.8K -$6.00 -- --
09/30/2018 Q3 -- $413.5K -$4.50 -- --
06/30/2018 Q2 -- $496.1K -$3.00 -- --
03/31/2018 Q1 -- $307.9K -$3.00 -- --
12/31/2017 Q4 -- $319.1K -$3.00 -- --
09/30/2017 Q3 -- $317.5K -$1.50 -- --
06/30/2017 Q2 -- $374.8K -$1.50 -- --
03/31/2017 Q1 -- $66.3K -$1.50 -- --
12/31/2016 Q4 -- $289.8K -$0.14 -- --
09/30/2016 Q3 -- $326.7K $0.60 -- --
06/30/2016 Q2 -- -- -$0.58 -- --
03/31/2016 Q1 -- -- -$1.60 -- --
12/31/2015 Q4 -- -- -$0.59 -- --
09/30/2015 Q3 -- -- -$1.05 -- --
06/30/2015 Q2 -- -- -$0.41 -- --
03/31/2015 Q1 -- -- -$0.60 -- --

Avalon Globocare Earnings Questions

  • How Much did Avalon Globocare Generate in Revenue Last Quarter?

    Avalon Globocare reported $345.2K worth of top line sales in its most recent quarter.

  • Did Avalon Globocare Beat Earnings Last Quarter?

    Avalon Globocare announced earnings per share of -$1.82 which represents a miss of analyst forecast a -- per share.

  • Is Avalon Globocare Profitable?

    Avalon Globocare reported $99.6K that represents $0.11 per share over the last quarter.

  • What is the Analyst Consensus for Avalon Globocare EPS Next Year?

    Avalon Globocare's earnings are forecast to grow from -$23.85 per share to -- per share next year representing an increase of --.

  • When is Avalon Globocare's Earnings Date?

    Avalon Globocare's next earnings date is May 30, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock